Mirion Technologies, Inc. Class A Common Stock (MIR)
24.02
-3.33 (-12.18%)
NYSE · Last Trade: Nov 13th, 7:06 PM EST
Detailed Quote
Previous Close
27.35
Open
26.83
Bid
24.15
Ask
24.31
Day's Range
24.01 - 27.12
52 Week Range
12.00 - 30.28
Volume
6,074,544
Market Cap
6.14B
PE Ratio (TTM)
218.36
EPS (TTM)
0.1
Dividend & Yield
N/A (N/A)
1 Month Average Volume
4,319,509
Chart
About Mirion Technologies, Inc. Class A Common Stock (MIR)
Mirion Technologies Inc. is a leading provider of advanced radiation detection and measurement solutions, serving a diverse range of industries such as healthcare, nuclear power, and defense. The company specializes in developing high-precision instruments and systems that are designed to detect, measure, and analyze radiation, enhancing safety and compliance for users around the globe. By leveraging cutting-edge technology and expertise, Mirion offers a comprehensive portfolio of products for both industrial and medical applications, including dosimetry, imaging, and monitoring systems. Their commitment to innovation and quality ensures that customers can effectively manage radiation exposure and maintain a safe working environment. Read More
A number of stocks fell in the afternoon session after investors continued to question how much more the superstar stocks can add to their already spectacular gains.
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution.
While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.
A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. This shift reflects growing caution over high valuations within the technology and artificial intelligence (AI) spheres. As market participants reassessed risk, they reallocated capital from growth-heavy indices, like the Nasdaq, to companies in areas like industrials and financials, which were perceived to be more reasonably priced.
Contributing to the positive momentum, markets remained hopeful that a prolonged 40-day government shutdown would be over.
The U.S. Senate approved a compromise funding package, which was pending a vote in the House. The potential end to the shutdown brought a sense of relief to markets.
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead.
They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
Mirion’s third quarter results were received positively by the market, reflecting strong momentum in its core nuclear power business and improved profitability across both its Nuclear and Safety and Medical segments. Management attributed the quarter’s performance to robust organic growth in the nuclear end market, accelerated orders for small modular reactors (SMRs), and continued margin expansion through procurement initiatives. CEO Tom Logan emphasized that approximately 80% of Mirion’s nuclear revenue derives from the installed base of operating reactors, providing a stable foundation for growth. Logan also highlighted the company’s efforts to strengthen its position through recent acquisitions and operational improvements, which fueled both top-line growth and margin gains.
The stocks in this article are all trading near their 52-week highs.
This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
Radiation safety company Mirion (NYSE:MIR) met Wall Streets revenue expectations in Q3 CY2025, with sales up 7.9% year on year to $223.1 million. Its non-GAAP profit of $0.12 per share was 17.1% above analysts’ consensus estimates.
Shares of radiation safety company Mirion (NYSE:MIR) jumped 15.5% in the afternoon session after it reported strong third-quarter 2025 financial results that beat Wall Street's profit expectations.
Radiation safety company Mirion (NYSE:MIR) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 7.9% year on year to $223.1 million. Its non-GAAP profit of $0.12 per share was 17.1% above analysts’ consensus estimates.
Mirion Technologies Q3 2025 earnings beat EPS estimates by 17.1%. The company shows strong momentum in nuclear markets and raises its full-year free cash flow guidance.
Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced results for the third quarter ended September 30, 2025.
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains.
This unpredictability can shake out even the most experienced investors.
A number of stocks fell in the afternoon session after new trade tensions and disappointing earnings from major tech companies weighed heavily on investor sentiment.
Mirion (NYSE: MIR) announced today that it will release financial results for third quarter 2025 after market close on Tuesday, October 28, 2025. Following the news release, the company will host a conference call the next day, Wednesday, October 29, 2025, at 11:00 am ET to discuss the results.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital,
and those that can maintain this trifecta year in and year out often become the legends of the investing world.
A number of stocks jumped in the afternoon session after confidence in the artificial intelligence market was renewed, pushing both the S&P 500 and Nasdaq to new all-time intraday highs.
